Effect of probiotic lactobacilli on faecal enzyme and genotoxic activity in human faecal water in the presence of the carcinogen PhIP in vitro

International Journal of Dairy Technology

Volumn 65, Issue 2, 2012, Pages 300-307

  Nowak, Adriana ^a   Katarzyna, Ślizewska ^a   Elzbieta, Klewicka ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Glucosidase; Glucuronidase; Genotoxicity; PhIP; Probiotics

Indexed keywords

LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI;

EID: 84860141646     PISSN: 1364727X     EISSN: 14710307     Source Type: Journal    
DOI: 10.1111/j.1471-0307.2011.00760.x     Document Type: Article

References (44)

1. Allsopp P and Rowland I R (2009) Potential protective effects of probiotics and prebiotics against colorectal cancer. In: Prebiotics and Probiotics Science and Technology, pp. 997-1048. Charalampopoulos D, Rastall R A, eds. Springer Verlag: Berlin/Heidelberg.
2. Augustsson K, Skog K, Jagerstad M and Steineck G (1997) Assessment of the human exposure to heterocyclic amines. Carcinogenesis 18 1931-1935.
3. Blasiak J and Kowalik J (2000) A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutation Research 649 135-145.
4. Blaut M and Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. Journal of Nutrition 137 S751-S755.
5. Blaut M, Marteau P and Miller G D (2006) Probiotics and the intestinal Microflora: what impact on the immune system, infections and aging? Current Nutrition and Food Sciences 2 79-95.
6. Bolognani F, Rumney C J and Rowland I R (1997) Influence of carcinogen binding by lactic acid producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chemistry and Toxicology 35 535-545.
7. Burns A J and Rowland I R (2000) Anti - carcinogenicity of probiotics and prebiotics. Current Issues in Intestinal Microbiology 1 13-24.
8. Burns A J and Rowland I R (2004) Anti - genotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutation Research 551 233-243.
9. Chadwick R W, George E and Claxton L D (1992) Role of intestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens. Drug Metabolism Reviews 24 425-492.
10. Commane D, Hughes R, Shortt C and Rowland I R (2005) The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutation Research 591 276-289.
11. Egert M, de Graaf A A, Smidt H, de Vos W M and Venema K (2006) Beyond diversity: functional microbiomics of the human colon. Trends in Microbiology 14 86-91.
12. Felton J S and Knize M G (1986) The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenyl-1H-imidazo[4, 5-b]pyridine (PhIP). Carcinogenesis 7 1081-1086.
13. Freeman H J (1986) Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on faecal enzymes in 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Cancer Research 46 5529-5532.
14. Gill C and Rowland I R (2003) Cancer. In: Functional Dairy Products, pp. 19-53. Sandholm M, Saarela M, eds. CRC press: Boca Raton.
15. Goldin B R (1996) The metabolic activity of the intestinal microflora and its role in colon cancer. Nutrition Today 31 S24-S27.
16. Goldin B R and Gorbach S L (1984) The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. American Journal of Clinical Nutrition 39 756-761.
17. Hughes R and Rowland I R (2000) Metabolic activities of the gut microflora in relation to cancer. Microbial Ecology in Health and Disease 12 179-185.
18. 1H nuclear magnetic resonance spectroscopy-based studies of the metabolism of food-borne carcinogen 2-amino-3-methylimidazo[4, 5-f]quinoline by human intestinal microbiota. Applied and Environmental Microbiology 71 5116-5123.
19. IARC (2000) GLOBOCAN 2000: Cancer Incidence, Mortality and Prelevance. Worldwide International Agency for Research on Cancer (IARC): Oxford.
20. Isolauri E (2004) Probiotics. Best Practice Research and Clinical Gastroenterology 18 299-313.
21. Kim D H and Jin Y H (2001) Intestinal bacteria beta-glucuronidase activity of patients with colon cancer. Archives in Pharmaceutical Research 24 564-567.
22. Klaude M, Eriksson S, Nygren J and Ahnstrom G (1996) The comet assay: mechanisms and technical consideration. Mutation Research 363 89-96.
23. de Kok T M C M and van Maanen J M S (2000) Evaluation of faecal mutagenicity and colorectal cancer risk. Mutation Research 463 53-101.
24. Ling W H, Korpela R, Mykkänen H, Salminen S and Hänninen O (1994) Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. Journal of Nutrition 124 18-23.
25. Naccari N, Galceran M T, Moyano E, Cristani M, Siracusa L and Trombetta D (2009) Presence of heterocyclic aromatic amines in smoked "Provola" cheese from Calabria". Food and Chemical Toxicology 47 321-327.
26. Nakagama H, Ochiai M, Ubagai T, Tajima R, Fujiwara K, Sugimura T and Nagao M (2002) A rat colon cancer model induced by 2-amino-1methyl-g-phenylimidazo[4, 5-b]pyridine, PhIP. Mutation Research 506-507 137-144.
27. Nowak A and Libudzisz Z (2009) Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines (HCA) in vitro. European Journal of Nutrition 48 419-427.
28. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T and Matsushita S (2006) The relationship between the consumption of meat, fat, coffee and risk of colon cancer: a perspective study in Japan. Cancer Letters 244 260-267.
29. O'Keefe S J D, Chung D, Mahmound N, Sepulveda A R, Manafe M, Arch J, Adada H and ban der Melve T (2007) Why do African Americans get more colon cancer than Native Africans? Journal of Nutrition 137 175S-182S.
30. Orrhage K, Sillerstrom E, Gustafsson J A, Nord C E and Rafter J (1994) Binding of heterocyclic amines by intestinal and lactic acid bacteria. Mutation Research 1 239-248.
31. Salminen S and Isolauri E (2006) Intestinal colonization, microbiota and probiotics. Journal of Pediatrics 149 S115-S120.
32. Shin A, Shrubsole M J, Ness R M, Wu H, Sinha R, Smalley W E, Shyr Y and Zheng W (2007) Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study. International Journal of Cancer 121 136-142.
33. Singh N P, McCoy M, Tice R R and Schneider E L (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 175 184-191.
34. Sinha R, Knize M G, Salmon C P, Brown E D, Rhodes D, Felton J S, Levander O A and Rothman N (1998) Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. Food Chemistry and Toxicology 36 289-297.
35. Smith E A and Macfarlane G T (1996) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. Journal of Applied Bacteriology 81 288-302.
36. Spanhaak S, Havenaar R and Schaafsma G (1998) The effect of consupmtion of milk fermented with Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. European Journal of Clinical Nutrition 52 899-907.
37. Terry P D, Lagergren J, Wolk A, Steineck G, Nyren O and Rothman N (2003) Dietary intake of heterocyclic amines and cancers of the oesophagus and gastric cardia. Journal of Womens Health 12 173-182.
38. Turesky R J (2007) Formation and biochemistry of carcinogenic heterocyclic aromatic amines in cooked meats. Toxicology Letters 168 219-227.
39. Van de Wiele T, Vanhaecke L, Boeckaert C, Peru K, Headley J, Verstraete W and Siciliano S (2005) Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environmental Health Perspectives 113 6-10.
40. Van Tassell R L, Kingston D G I and Wilkins T D (1990) Metabolism of dietary genotoxins by the human colonic microflora: the fecapentaenes and heterocyclic amines. Mutation Research 238 209-221.
41. Vanhaecke L, Van Hoof N, Van Brabandt W, Soenen B, Heyerick A, De Kimpe N, De Keukeleire D, Verstraete W and Van de Wiele T (2006) Metabolism of the food associated carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human intestinal microbiota. Journal of Agriculture and Food Chemistry 54 3454-3461.
42. Vanhaecke L, Derycke L, Le Curieux F, Lust S, Marzin D, Verstraete W and Bracke M (2008) The microbial PhIP metabolite 7-hydroxy-5-methyl-3-phenyl-6, 7, 8, 9tetrahydropyrido[30, 20:4, 5]-imidazo[1, 2-a]pyrimidin-5-ium chloride (PhIP-M1) induces DNA damage, apoptosis and cell cycle arrest towards Caco-2 cells. Toxicology Letters 178 61-69.
43. Woodmansey E J (2007) Intestinal bacteria and ageing. Journal of Applied Microbiology 102 1178-1186.
44. Xu H, Heinze M, Chen S, Cerniglia C E and Chen H (2007) Anaerobic metabolism of 1-amino-2-naphthol-based azo dyes (sudan dyes) by human intestinal microflora. Applied and Environmental Microbiology 73 7759-7762.